本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nurix Therapeutics

16.69
-0.2800-1.65%
盘后16.690.00000.00%17:17 EDT
成交量:88.82万
成交额:1,491.50万
市值:17.26亿
市盈率:-5.27
高:17.13
开:17.04
低:16.52
收:16.97
52周最高:22.50
52周最低:8.20
股本:1.03亿
流通股本:8,636.18万
量比:0.71
换手率:1.03%
股息:- -
股息率:- -
每股收益(TTM):-3.1650
每股收益(LYR):-3.0514
净资产收益率:-61.40%
总资产收益率:-31.50%
市净率:3.59
市盈率(LYR):-5.47

数据加载中...

2024/07/11

重要事件披露

Form 8-K - Current report
2024/07/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/17

重要事件披露

Form 8-K - Current report
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

重要事件披露

Form 8-K - Current report
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

重要事件披露

Form 8-K - Current report
2024/04/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/10

重要事件披露

Form 8-K - Current report
2024/04/09

重要事件披露

Form 8-K - Current report
2024/03/11

重要事件披露

Form 8-K - Current report
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]